India's Senores Pharmaceuticals jumps on Q3 profit rise
** Shares of Senores Pharmaceuticals SENO.NS rise as much
as 17.2% to 584.05 rupees
** SENO reports Q3 consol net profit more than doubled Y/Y
to 171.8 mln rupees ($2.1 mln), rev from ops rose 31% Y/Y to
1.03 bln rupees
** More than 3.6 mln shares change hands, 2.2x of 30-day avg
since listing on Dec. 30
** Since listing stock is down 10.3%
($1 = 86.4825 Indian rupees)
(Reporting by Ashish Chandra in Bengaluru)
((ashish.chandra@thomsonreuters.com (+91 7982114624))
Recent news on Senores Pharmaceuticals
See all newsBrief: Senores Pharmaceuticals Approves Re-Appointment Of Swapnil Jatinbhai Shah As Managing Director
Brief: Senores Pharmaceuticals Says U.S.FDA Completes Inspection At Unit's Vadodara Facility
Brief: Senores Pharmaceuticals Says To Incorporate Units In Mexico, Canada
Brief: Senores Pharmaceuticals Ltd June-Quarter Consol Net Profit 307.2 Million Rupees
Brief: Senores Pharmaceuticals March-Quarter Consol Net Profit 316.1 Million Rupees